Not effective Corrigendum to Commission Regulation (EU) 2015/845 of 27 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, chlorantraniliprole, cyantraniliprole, dicamba, difenoconazole, fenpyroximate, fludioxonil, glufosinate-ammonium, imazapic, imazapyr, indoxacarb, isoxaflutole, mandipropamid, penthiopyrad, propiconazole, pyrimethanil, spirotetramat and trinexapac in or on certain products ( Official Journal of the European Union L 138 of 4 June 2015 )
Vyhláška č. 845/2015
Important dates
Documents and links
Corrigendum to Commission Regulation (EU) 2015/845 of 27 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, chlorantraniliprole, cyantraniliprole, dicamba, difenoconazole, fenpyroximate, fludioxonil, glufosinate-ammonium, imazapic, imazapyr, indoxacarb, isoxaflutole, mandipropamid, penthiopyrad, propiconazole, pyrimethanil, spirotetramat and trinexapac in or on certain products
On page 27, paragraph 2(a):
for:
‘In Part A, the columns for chlorantraniliprole, dicamba, difenoconazole, glufosinate-ammonium, imazapic, imazapyr, mandipropamid, penthiopyrad and spirotetramat are replaced by the following:’;
read:
‘In Part A, the columns for chlorantraniliprole, dicamba, difenoconazole, fenpyroximate, glufosinate-ammonium, imazapic, imazapyr, mandipropamid, penthiopyrad and spirotetramat are replaced by the following:’.